drugset / Trial / NCT06842355
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, and identify potentially effective dose(s) of TYRA-300 in children with achondroplasia with open growth plates.
Timeline
- Start
- 2025-03-04
- Primary completion
- 2030-01
- Completion
- 2030-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TYRA-300 | Unknown | 0.125 mg/kg | — |
| Subject | TYRA-300 | Unknown | 0.25 mg/kg | — |
| Subject | TYRA-300 | Unknown | 0.375 mg/kg | — |
| Subject | TYRA-300 | Unknown | 0.5 mg/kg | — |